Showing results (11-20 of 95) with videos related to
Sort By:
Pageof 10
Journal of Personality and Social Psychology|February 1, 1996
Postbereavement depressive mood and its prebereavement predictors in HIV+ and HIV- gay menS Folkman, M Chesney, L Collette, et al.Medical Mycology|March 29, 2001
Reliability of clinical research on invasive fungal infections: a systematic review of the literatureS Ascioglu, B E de Pauw, J P Donnelly, et al.Journal of Consulting and Clinical Psychology|August 1, 1994
Caregiver burden in HIV-positive and HIV-negative partners of men with AIDSS Folkman, M A Chesney, M Cooke, et al.The Western Journal of Medicine|July 1, 1987
House calls in UtahM S Schueler, D L Harris, G K Goodenough, et al.British Journal of Cancer|January 26, 2000
Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of CancerF H Schröder, L Collette, T M de Reijke, et al.The Journal of Urology|October 12, 2000
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer TrialsA Van Der Meijden, R Sylvester, L Collette, et al.AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|December 1, 1996
Differences between gay men in primary relationships and single men: implications for preventionC C Hoff, T J Coates, D C Barrett, et al.Archives of Internal Medicine|January 23, 1998
Informal caregivers and the intention to hasten AIDS-related deathM Cooke, L Gourlay, L Collette, et al.Journal of the National Cancer Institute|July 3, 1996
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative GroupJ L Lefebvre, D Chevalier, B Luboinski, et al.The Prostate|June 8, 2001
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differencesL Collette, U E Studer, F H Schröder, et al.Pageof 10